ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 680721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 680721; 2) Community: the network communities that were significantly associated with the response to NSC 680721; 3) Molecule: the relationships between components within communities and NSC 680721; 4) MDR: the compounds that were significantly associated with the NSC 680721.

NSC Compound Enrichment Correlation
NSC 287459 Cytarabine AY 0.017138169515949 -0.12306306
NSC 292147 12-Hydroxyindolo[2,1-b]quinazoline-6(12H)-one 0.017138169515949 -0.071934924
NSC 33566 Null 0.017138169515949 -0.2109281
NSC 628122 Null 0.017138169515949 -0.2585737
NSC 666871 Null 0.017138169515949 0.21334649
NSC 676776 Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-D-xylopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylopyranosyl)]- 0.017138169515949 -0.40497115
NSC 681638 Camptothecin Derivative 0.0171381695159491 0.20252441
NSC 683239 2-(p-Toluene sulfonyl)-L-glutamic acid phenyl hydrazide 0.0171381695159491 -0.095204944
NSC 686428 Null 0.0171381695159491 0.2794418
NSC 693573 Null 0.0171381695159491 0.0073431327
Total:98  Current:38    [First] [Prev] [Next] [Last]